Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Evan Conte

Orthopaedic Surgery Trenton, NJ Medical Doctor

NPI 1073883237 CMS profile 1365879

1079 White Horse Mercerville Rd, Trenton, NJ 08610

Open in the dashboard

General payments

$35,954

221 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Evan Conte of Trenton, NJ is reported in the CMS Open Payments database as having received $35,954 across 221 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 86th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,541 26
2024 General $10,795 72
2023 General $2,442 16
2022 General $8,305 43
2021 General $741 16
2020 General $32 2
2019 General $11,097 46

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Evan Conte
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Evan Conte were reported at $2,541. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Evan Conte Orthopaedic Surgery median Middle half National median
2019 $11,097 $644 $140–$2,844 $163
2020 $32 $312 $75–$1,860 $114
2021 $741 $520 $117–$2,495 $132
2022 $8,305 $598 $128–$2,731 $149
2023 $2,442 $461 $128–$2,264 $160
2024 $10,795 $497 $134–$2,475 $164
2025 $2,541 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Arthrex, Inc. $18,700 61 payments
  2. Zimmer Biomet Holdings, Inc. $5,378 43 payments
  3. SeaPearl Inc $4,110 41 payments
  4. Medical Device Business Services, Inc. $4,087 12 payments
  5. Vericel Corporation $1,670 17 payments
  6. DePuy Synthes Sales Inc. $842 15 payments
  7. Dynasplint Systems Inc. $438 8 payments
  8. Stryker Corporation $191 6 payments
  9. Boston Scientific Corporation $99 2 payments
  10. Baxter Healthcare $91 1 payment
  11. Other $348 15 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $11,000 4 payments
  2. Travel and Lodging $9,771 46 payments
  3. Food and Beverage $7,091 163 payments
  4. Education $4,942 6 payments
  5. Consulting Fee $1,800 1 payment
  6. Compensation for serving as faculty or as a speaker for a medical education program $1,350 1 payment
Products named General payments · program years 2019–2025
  1. Comprehensive Shoulder System $4,517 27 payments
  2. HEALIX $3,166 7 payments
  3. MONOVISC $1,800 1 payment
  4. VISUALIZATION $1,800 1 payment
  5. MACI $1,603 13 payments
  6. Dynasplint $438 8 payments
  7. Comprehensive Reverse Extremities $278 3 payments
  8. HEALIX KNOTLESS PEEK $271 4 payments
  9. Comprehensive Reverse Extremities $252 4 payments
  10. VAPR $176 2 payments
  11. Other $2,475 60 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 3 drugs

Part D claims

127

Median for Orthopedic Surgery: 203

Drug cost

$614

Median for Orthopedic Surgery: $1,433

Branded share of claims

0%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Diclofenac Sodium Generic 44 $329
Methylprednisolone Generic 57 $237
Amoxicillin Generic 26 $49

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 48 billing codes

Paid by Medicare

$130,010

Of which drugs: $13,233

Medicare patients

264

Average age 74

Services billed

3,112

146 women, 118 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 36%
Ischemic heart disease 34%
Depression 22%
Chronic kidney disease 19%
Atrial fibrillation 17%
Cancer 15%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Hyaluronan or derivative, trivisc, for intra-articular injection, 1 mg J7329 Office 28 2,175 $12,531
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 61 120 $84

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

221 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in New Jersey

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record